Daniel J. Gerritzen Sells 10,000 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) General Counsel Daniel J. Gerritzen sold 10,000 shares of OrthoPediatrics stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $29.30, for a total value of $293,000.00. Following the completion of the transaction, the general counsel now owns 77,304 shares in the company, valued at approximately $2,265,007.20. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

OrthoPediatrics Stock Up 8.2 %

Shares of NASDAQ KIDS opened at $32.56 on Friday. The company has a 50 day simple moving average of $30.23 and a 200 day simple moving average of $29.84. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.45 and a quick ratio of 1.99. OrthoPediatrics Corp. has a 1 year low of $23.10 and a 1 year high of $38.99. The firm has a market cap of $775.87 million, a PE ratio of -33.92 and a beta of 1.19.

Hedge Funds Weigh In On OrthoPediatrics

Several large investors have recently modified their holdings of the business. International Assets Investment Management LLC increased its holdings in OrthoPediatrics by 3,151.4% in the fourth quarter. International Assets Investment Management LLC now owns 1,203 shares of the company’s stock valued at $37,000 after purchasing an additional 1,166 shares during the period. CWM LLC raised its position in shares of OrthoPediatrics by 16,283.3% during the fourth quarter. CWM LLC now owns 983 shares of the company’s stock worth $32,000 after acquiring an additional 977 shares during the last quarter. Versor Investments LP acquired a new position in shares of OrthoPediatrics in the fourth quarter worth approximately $260,000. Jump Financial LLC bought a new stake in OrthoPediatrics in the fourth quarter valued at approximately $579,000. Finally, Triodos Investment Management BV increased its position in OrthoPediatrics by 40.0% during the 4th quarter. Triodos Investment Management BV now owns 35,000 shares of the company’s stock valued at $1,138,000 after purchasing an additional 10,000 shares during the period. Institutional investors own 69.05% of the company’s stock.

Wall Street Analyst Weigh In

KIDS has been the topic of a number of recent analyst reports. JMP Securities reiterated a “market outperform” rating and issued a $50.00 target price on shares of OrthoPediatrics in a research report on Tuesday, May 7th. Truist Financial reaffirmed a “hold” rating and set a $30.00 price target (down from $35.00) on shares of OrthoPediatrics in a report on Thursday, August 8th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $42.00 price objective on shares of OrthoPediatrics in a research note on Friday, August 16th.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.